VPS37C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.815600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.664200E-01
Normal-vs-Stage2
6.947600E-01
Normal-vs-Stage3
5.857200E-01
Normal-vs-Stage4
3.172000E-01
Stage1-vs-Stage2
3.252200E-01
Stage1-vs-Stage3
6.044200E-01
Stage1-vs-Stage4
9.142300E-02
Stage2-vs-Stage3
1.574210E-01
Stage2-vs-Stage4
1.664020E-01
Stage3-vs-Stage4
1.299770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.302800E-01
Normal-vs-AfricanAmerican
5.826400E-01
Normal-vs-Asian
5.728000E-01
Caucasian-vs-AfricanAmerican
6.880400E-01
Caucasian-vs-Asian
2.304800E-01
AfricanAmerican-vs-Asian
6.498000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.415600E-01
Normal-vs-Female
8.557200E-01
Male-vs-Female
5.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.655400E-01
Normal-vs-Age(41-60Yrs)
5.149200E-01
Normal-vs-Age(61-80Yrs)
8.900600E-01
Normal-vs-Age(81-100Yrs)
8.578400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.105800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.713800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.554600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.182800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.669800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.899000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.662200E-01
Normal-vs-Daily Drinker
8.518800E-01
Normal-vs-Weekly Drinker
7.701600E-01
Normal-vs-Occasional Drinker
5.013000E-01
Normal-vs-Social Drinker
6.827200E-01
Non Drinker-vs-Daily Drinker
7.328200E-01
Non Drinker-vs-Weekly Drinker
5.999400E-01
Non Drinker-vs-Occasional Drinker
3.279200E-01
Non Drinker-vs-Social Drinker
5.618000E-01
Daily Drinker-vs-Weekly Drinker
8.434400E-01
Daily Drinker-vs-Occasional Drinker
5.747600E-01
Daily Drinker-vs-Social Drinker
8.357800E-01
Weekly Drinker-vs-Occasional Drinker
8.014000E-01
Weekly Drinker-vs-Social Drinker
9.834400E-01
Occasional Drinker-vs-Social Drinker
7.017800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.596820E-01
Normal-vs-Grade 2
2.593700E-02
Normal-vs-Grade 3
1.202170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.023600E-02
Grade 1-vs-Grade 3
8.197300E-03
Grade 1-vs-Grade 4
1.596820E-01
Grade 2-vs-Grade 3
5.386800E-01
Grade 2-vs-Grade 4
2.593700E-02
Grade 3-vs-Grade 4
1.202170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.788600E-01
Normal-vs-NonDiabetic
7.340800E-01
Diabetic-vs-NonDiabetic
2.473400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.627960E-01
Normal-vs-NoPancreatitis
8.943400E-01
Pancreatitis-vs-NoPancreatitis
4.104300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.551800E-01
Normal-vs-N1
7.694800E-01
N0-vs-N1
9.357400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.839200E-01
Normal-vs-TP53-NonMutant
5.987400E-01
TP53-Mutant-vs-TP53-NonMutant
1.804550E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
